“Eat me” and “danger” signals, such as calreticulin (CRT), are expressed on the surface of tumour cells undergoing ICD and can enable immature DCs (iDCs) to phagocytize tumour cells and present TAA epitopes to T cells through MHC class I or II molecules [14, 15]. The gene discussed is HLA-C; the disease is neoplasm.